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PURPOSE. Rare interchange haplotypes in exon 3 of the OPN1LW and OPN1MW opsin genes
cause X-linked myopia, color vision defect, and cone dysfunction. The severity of the disease
varies on a broad scale from nonsyndromic high myopia to blue cone monochromatism. Here,
we describe a new genotype–phenotype correlation attributed to rare exon 3 interchange
haplotypes simultaneously present in the long- and middle-wavelength sensitive opsin genes
(L- and M-opsin genes).
METHODS. A multigenerational family with X-linked high myopia and cone dystrophy was
investigated.
RESULTS. Affected male patients had infantile onset myopia with normal visual acuity and color
vision until their forties. Visual acuity decreased thereafter, along with the development of
severe protan and deutan color vision defects. A mild decrease in electroretinography
response of cone photoreceptors was detected in childhood, which further deteriorated in
middle-aged patients. Rods were also affected, however, to a lesser extent than cones. Clinical
exome sequencing identified the LVAVA and MVAVA toxic haplotypes in the OPN1LW and
OPN1MW opsin genes, respectively.
CONCLUSION. Here, we show that LVAVA haplotype of the OPN1LW gene and MVAVA haplotype
of the OPN1MW gene cause apparently nonsyndromic high myopia in young patients but lead
to progressive cone–rod dystrophy with deuteranopia and protanopia in middle-aged patients
corresponding to a previously unknown disease course. To the best of our knowledge, this is
the first report on the joint effect of these toxic haplotypes in the two opsin genes on
chromosome X.
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The long- and middle-wavelength sensitive opsin genes (L-and M-opsin genes; OPN1LW, OPN1MW, respectively)
reside in a head-to-tail tandem array on Xq28 and share 98%
nucleotide identity.1 The normal gene array is composed of a
locus control region (LCR), a single L gene followed by one or
more M genes with only the first two genes in the array
expressed due to their proximity to the upstream cis-regulatory
LCR.2–5 Mutations in the LCR, L- (OPN1LW), and M- (OPN1MW)
opsin genes on Xq28 lead to various X-linked cone-photore-
ceptor disorders including red-green color vision defects
(Online Mendelian Inheritance in Man [OMIM] #303800 and
#303900), X-linked cone dysfunction (Bornholm Eye Disease
[BED], OMIM #300843), X-linked cone dystrophy, and blue
cone monochromatism (BCM; OMIM #303700).1,4,6–25 Rare
exon 3 interchange haplotypes are a recently described group
of mutations of the opsin genes on chromosome X, which
involve amino acid residues 153, 171, 174, 178, and 180, and
their name is the acronym of the one letter code of specific
amino acids present at these locations. Normal opsin genes
specify the haplotypes LVAIS and MVAIA in the L and M genes,
respectively. Toxic opsin variants that have been discovered in
human opsin-related diseases so far include LVAVA, LIAVA,
LIAVS, LIVVA, MVVVA, and MIAVA.4,11,26–31 Patients reported so
far with an exon 3 interchange haplotype are summarized in
the Supplementary Material. Toxic exon 3 interchange haplo-
types have been commonly reported in BED.14,26,29,32–34 BED
was originally described in a family from the Danish island of
Bornholm.32 The second family with BED from Minnesota had
also a Danish origin.14 Affected males had infantile onset
myopia with astigmatism, decreased visual acuity from child-
hood, subnormal photopic, and normal scotopic electroretino-
gram (ERG) parameters with normal macular appearance. The
disease showed no progression with age. The first family had a
deutan while the second had a protan color vision defect. The
disease was accounted for by the LVAVA interchange haplotype
in one of the first two genes in the opsin gene array in both
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families. This observation was the first to identify LVAVA
haplotype as a cause of BED.26 LVAVA haplotype associated to a
similar phenotype with either protan or deutan color vision
defect in four individuals from four recently reported
families.28 Rare interchange haplotypes have been shown to
cause skipping of exon 3, a frame shift and premature
termination of translation. However, in contrast to the LIAVA
haplotype, there was a residual low level of correctly spliced
opsin mRNA with the LVAVA or MIAVA haplotypes observed
indicating some amount of functionally normal opsin pro-
teins.29,35 Accordingly, color vision defect was explained by
the lack of either L- or M-opsin genes in the first two positions
of the opsin gene array instead of a direct opsin inactivating
effect in patients with the LVAVA haplotype.26 These observa-
tion suggests that the LVAVA haplotype has a dominant effect
on the development of myopia, a key element of BED,
however, it is transcribed at a sufficient level to provide
normal opsin function.26 The strongest clinical evidence
supporting this hypothesis is the report on two Chinese
families with nonsyndromic high myopia associating to the
LVAVA haplotype.33,34 However, this represents a strikingly
different phenotype than observed in BED patients with the
same haplotype. Interestingly, the LVAVA haplotype is unique
among interchange mutations in another aspect as well.
According to its definition, BED is a nonprogressive disease.
However, a spectral-domain optical coherence tomography
(SD-OCT) and adaptive optics scanning laser ophthalmoscopy
analysis of two patients with an LVAVA-only genotype showed
characteristic signs of progressive macular dystrophy including
overall retinal thinning, mottling of photoreceptor inner
segments, and structural disruption of the inner retina and
the outer nuclear layer.27 This finding indicated that LVAVA
haplotype causes progressive degenerative changes that result
in damage to neighboring cells in addition to those expressing
the mutated opsin. Moreover, these patients gradually devel-
oped clinical signs of BED during their elementary school
years, representing a somewhat later disease onset than
observed in other BED patients.27 Taken together, our
understanding on the genotype–phenotype correlation associ-
ating to the LVAVA haplotype has largely developed since the
first description of BED as a stationary disease with color vision
deficiency. Recent papers highlight that LVAVA expressing
cones remain functional in early life and degenerate lat-
er.27,29,33–35 Phenotypic variability observed in patients with
the LVAVA haplotype can presumably be accounted for by
other genetic modifiers, the mutational status of the opposite
opsin gene, and the number of cones expressing the mutant
opsin in the retina. In the present paper, we describe a large
multigeneration family with X-linked high myopia and late
onset cone dysfunction. The disease is caused by the rare
interchange haplotypes LVAVA and MVAVA in the L- and M-
opsin genes, respectively. This combination has not been
reported so far and provides a unique opportunity to
investigate the joint effect of these haplotypes. Moreover, the
large multigeneration family provides excellent possibility to
observe disease phenotype across different generations and
gain insight into disease progression. Besides, we followed the
proband for 8 years in order to document disease progression
in a single individual. Our results shed light on a new
phenotype of cone dystrophy associating to the LVAVA/MVAVA
rare interchange haplotypes in the L- and M-opsin genes. This is
the first report on the combination of LVAVA and MVAVA
haplotypes in the L- and M-opsin genes, respectively. Our
findings provide robust clinical evidence for late onset
progressive cone dystrophy indicating that these haplotypes
have little or no effect on color vision and visual acuity in early
life but lead to slowly progressive late-onset cone–rod
dystrophy characterized by a progressively declining visual
acuity along with color vision deficiency in patients older than
40 years.
METHODS
Patients and Ophthalmology Investigations
In the present study, we have investigated members of a three-
generation family with X-linked high-grade myopia. Autorefrac-
tometry was performed using a Topcon KR 8100 equipment
(Topcon Corp., Tokyo, Japan). Color vision was tested under
standardized conditions, with pseudoisochromatic plates
(Tafeln und Pru¨fung des Farbensinnes, 29. Auflage, 2002),
the Farnsworth Munsell 100-hue test and the anomaloscope
Nagel type II test. Color fundus photographs were taken with a
Zeiss FF450þIR fundus camera (Carl Zeiss AG, Jena, Germany)
mounted with a ZK-5 color sensor (Allied Vision Technologies
GmbH, Stadtroda, Germany) operated with Zeiss Visupack 4.4
software. Optical coherence tomography and confocal-scan-
ning laser fundus autofluorescence (FAF) imaging was per-
formed with Spectralis OCT (Heidelberg Engineering,
Heidelberg, Germany). Electroretinography was executed with
Ganzfeld Q400 equipment (Roland Consult GmbH, Branden-
burg, Germany) using standard International Society for
Clinical Electrophysiology of Vision parameters.36 Measures
of photoreceptor dysfunction were defined as: mild (70%–99%
of normal amplitude), moderate (30%–69% of normal), severe
(1%–29% of normal), or undetectable. The research was
performed according to the Declaration of Helsinki and was
approved by the local institutional review boards. Written
informed consent was obtained from participating family
members prior to investigation.
Isolation of Genomic DNA
Genomic DNA was isolated from EDTA or citrate anticoagulat-
ed blood using the QIAamp Blood Mini kit according to the
manufacturer’s instructions (Qiagen GmbH, Hilden, Germany).
Comparative Genomic Hybridization Array
The copy number variations (CNVs) of X chromosome were
analyzed by comparative genomic hybridization array (array
CGH: Roche, NimbleGen, Madison, WI, USA) on genomic DNA
from the proband sent to the NimbleGen custom microarray
services facility (NimbleGen Systems of Iceland, LLC, Reykja-
vik, Iceland). The genomic DNA labelled with Cy3 or Cy5 using
NimbleGen Dual Color DNA labelling kit and co-hibridizyed to
the arrays (Nimble Gen CGH Services: Guide to your CGH data
v5p1). The design of the array was based on the human
reference genome NCBI36/hg18.
Sanger Sequencing of RPGR ORF15
The genomic DNA of the index patient was screened for
disease-associated sequence alterations in exon ORF15 of
RPGR gene by sequencing of PCR products. ORF15 is an
alternative 30 terminal exon that contains exon 15 and extends
into intron 15.37 The amplification consisted of 35 cycles. We
applied previously published primers.38 Cycling conditions of
PCR reactions were in case of 15.1, 15.2, 15.3, and 15.5
fragments: initial denaturation 958C for 10 minutes, denatur-
ation 948C for 30 seconds, annealing 558C for 30 seconds, and
elongation 728C for 1 minute. The amplification consisted of 40
cycles. The conditions of the 982-bp length 15.4 fragment was:
initial denaturation 958C for 10 minutes, denaturation 948C for
45 seconds, annealing 608C for 45 seconds, and elongation
728C for 1.5 minutes. Polymerase chain reaction amplicons
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were identified with ABI BigDye Terminator cycle sequencing
kit version 3.1 (Applied Biosystems, Foster City, CA, USA) on an
ABI 310 sequencer (Applied Biosystems). The sequenced
profiles were compared with the retinitis pigmentosa GTPase
regulator (RPGR) reference genome (NM_001034853) in
National Center for Biotechnology database.
Clinical Exome Sequencing
Clinical exome sequencing was performed on the sample of
the proband (V:1) and of the mother of the proband (IV:3).
Exome sequencing was carried out by TruSight One Sequenc-
ing Panel (Illumina, San Diego, CA, USA) that covers 4813
clinically relevant genes. Library preparation was done
according to the manufacturer’s instruction and sequencing
was performed using Illumina Miseq system (Illumina). At least
20-fold coverage was observed in 92% of the target regions.
The reads were mapped against the human reference genome
NCBI37/hg19. For bioinformatic analysis NextGene Software
version 2.3.4 was used (SoftGenetics, State College, PA, USA).
The analysis pipeline was based on X-linked recessive
inheritance. The coding regions of X-linked genes and the
splicing regions (65 bp) were analyzed. The silent and
noncoding variants were excluded. Ensembl, HGMD, and
ExAC databases were used for analysis of the variants.
Validation and Segregation Testing of OPN1LW,
OPN1MW, and CACNA1F Variants
Putative variants detected by clinical exome sequencing in
OPN1LW, OPN1MW (c.532A>G/p.Ile178Val and c.538T>G/
p.Ser180Ala), and CACNA1F (c.1843G>T/p.Ala615Ser) genes
were confirmed by Sanger sequencing using sequence specific
primer pairs: OPN1LW/OPN1MW F 50-TAAGCAGGACAGTGG
GAAGC-30; OPN1LW/OPN1MW R 50-GGCCCAGAGAAAGGAA
GTG-30, CACNA1F-F: GCCTCTCTCCCCACAGAGTA and CAC
NA1F-R: TGCTCAATGAATGGTGAAGC. Cycling conditions of
PCR reaction were: initial denaturation 958C for 10 minutes,
denaturation 948C for 30 seconds, annealing 558C for 30
seconds, and elongation 728C for 1 minute. Polymerase chain
reaction amplicons were sequenced on an ABI310 sequencer
(Applied Biosystems). These analyses were performed in all
available family members (IV:3, IV:5, IV:7, V:1, V:3, VI:6).
RESULTS
Clinical Findings
We have investigated a three-generation family with X-linked
high myopia. Three of the precedent generations were also
included in the family tree (Fig. 1). Living family members
unanimously confirmed that male family members of the
second generation suffered from serious visual disability,
however its cause remained undisclosed. (Subject IV:9 refused
to participate in the study). We have followed the proband
(patient V:1) for 8 years. Previous clinical data were available
on patient IV:5 that were retrospectively analyzed. Clinical data
of patients are summarized in a chronological order in Table 1.
All affected members of the family were males who developed
substantial myopia before school age. The refraction of patient
IV:5 remained stable thereafter, while others experienced a
gradual increase of myopic refraction throughout their life.
Spherical equivalent of patients was between 5.0 and 21.0
diopters upon examination (patient IV:5 underwent corneal
refractive surgery at the age of 40, therefore we used
preoperative refractive data). The youngest patient had no
complaints, while others suffered from photophobia, gradually
increasing difficulty identifying mixed colors and distinguish-
ing between small color hue differences. Patients complained
neither of night blindness nor a declined in their visual acuity.
Even the oldest living affected family member (IV:5, 62-years
old) considered his visual acuity satisfactory to maintain his
regular work and everyday life. A significant decline in visual
acuity could only be detected in the two oldest patients (IV:5,
IV:7), both older than 50 years. A deutan/protan color
blindness developed gradually and simultaneously along with
the visual acuity decline in these patients, which could not be
detected in younger individuals. However, patient VI:6 was
found to have a mild deutan color vision defect with
pseudoisochromatic charts and the Nagel anomaloscope at
the age of 11 years. On the other hand, he performed well on
the FM 100 hue test excluding a severe color vision defect.
Ophthalmoscopic examination revealed myopic fundus chang-
es with a central pigmented epithelial layer atrophy in the
proband and patients V:3, IV:5 and IV:7, all older than 40 years.
The 11-year-old patient (VI:6) had normal fundus appearance.
Autofluorescent fundus images showed central patchy drop-
outs in older patients (V:1, V:3, IV:5 and IV:7) indicating severe
central pigmented epithelial layer atrophy. Central hyper-
reflective ring, a characteristic sign of cone dystrophies, was
detected in patients IV:7 and VI:6. Spectral-domain OCT
examination showed disruption of the pigmented epithelial
layer, a thinning of the outer nuclear layer and photoreceptor
outer segments in patients older than 40 years. (Fig. 2.)
Electroretinography
The 11-year-old patient (VI:6) showed normal scotopic rod
response and mildly decreased response upon maximal
scotopic light stimulation (ERG 3.0). Moderately reduced
amplitudes were registered under single photopic stimulation
and a mild reduction was detected in the response for
photopic 30-Hz flicker stimulation of cone photoreceptors.
Patients V:1 (proband) and IV:7 showed severely reduced rod
response, moderately reduced amplitudes to maximal scotopic
light stimuli and undetectable electrical activity of cone
FIGURE 1. Pedigree of the family affected by X-linked high myopia.
Arrow indicates the proband with L-opsin- LVAVA and M-opsin-MVAVA
haplotype; square: male, circle: female, diagonal lines indicate
deceased family members, blackened symbol indicates clinically
affected individuals, and half blackened symbol indicates heterozy-
gotes.
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photoreceptors under photopic conditions in response to
single or flicker stimuli. Patient IV:5 (62-years old) showed
moderately reduced rod response, mildly reduced amplitudes
to maximal scotopic light stimuli, and undetectable electrical
activity of cone photoreceptors under photopic conditions in
response to single or flicker stimuli (Fig. 3).
Molecular Genetic Investigations
Array CGH. No chromosomal rearrangements or copy
number variations of the X chromosome could be detected
with array CGH (data not shown).
RPGR ORF15 Analysis. Mutations in the RPGR gene on
Xp21 are the most common causes of X-linked cone dystrophy.
ORF15 of RPGR gene has been identified as a mutation
hotspot.39,40 In the proband we found an already known in-
frame 12-nt deletion polymorphism in nucleotides 3074_3085
resulting in elimination of four amino acids (rs201134185,
c.3074_3085delTGGAAGGGGAGG, p.Val1025_Glu1028del).
The deletion has no clinical significance.
Clinical Exome Sequencing. We detected 47 hemizygous
variants in the proband and 50 heterozygous variants in the
proband’s mother on the X chromosome. Seventeen of these
variants were found in both samples (Table 2). Ensembl,
dbSNP, and Exac databases checked the minor allele frequen-
cies of these variants. Filtering for minor allele frequencies
(MAF) and clinical significance yielded three variants putatively
associating to diseases in our pedigree. The c.1843G>T
(p.Ala615Ser) variant in the CACNA1F gene had a MAF less
than 0.01 and the gene is known to be associated with X-linked
incomplete congenital stationary night blindness and A˚land
island eye disease.41,42 The mutation could not be detected in
any other family members by Sanger sequencing. We found
two variants (c.532A>G, p.Ile178Val and c.538T>G, p.Ser180-
Ala) in the OPN1LW gene and one variant (c.532A>G,
p.Ile178Val) in the OPN1MW gene, which are known to form
the LVAVA and MVAVA rare interchange haplotypes in the L- and
M-opsin genes, respectively. No other nucleotides were
detected in corresponding positions in any of the reads
indicating only mutated opsin genes in the array. Sanger
sequencing unequivocally confirmed these haplotypes with
only one nucleotide detectable at each position in every
affected family member. However, there were nucleotides
coding a leucine and a methionine simultaneously detected at
amino acid position 153, originating from the L- and M-opsin
genes, as expected (Fig. 4). Based on these results we can
conclude that the LVAVA and MVAVA haplotypes cosegregated
with the disease in the entire family. We could not detect any
additional nucleotide variations including SNPs or any other
mutations in the L- and M-opsin genes of the proband and his
mother. OPN1MW2, an additional M-opsin gene was only
detected in the mother.
DISCUSSION
We have investigated a three-generation family with X-linked
high myopia. Initially, the proband was suspected to suffer
from nonsyndromic X-linked high myopia. However, dimin-
ished rod and extinguished cone response upon ERG
examination indicated a simultaneous X-linked cone dystrophy
confirmed by macular dystrophy and combined red and green
color blindness (blue monochromatism) of older family
members. We failed to detect any mutations in the ORF15 of
the RPGR gene, a known locus for X-linked cone dystro-
phy.39,40 X chromosome–specific high-resolution array CGH
detected neither rearrangements nor copy number variations
in the proband. Clinical exome sequencing analysis identified
three putative variants including c.1843G>T (p.Ala615Ser) in
the CACNA1F gene and the LVAVA and MVAVA rare interchange
haplotypes in exon 3 of the L- and M-opsin genes, respectively.
The pathogenic role of the CACNAF1 mutation was already
TABLE 1. Clinical Data of Affected Males
ID
Age,
y Refraction
Best
Corrected
Visual
Acuity
Color
Vision ERG Fundus/OCT
Axial
Length,
mm
IV:5 40* OD 4.25 D sph 0.5 D cyl 20/20 NA NA Normal fundus ODS OD 25.16
OS 5.25 D sph 1.5 D cyl 20/20 OS 25.51
57 OD þ1.75 DS 20/25 Deuteranomaly NA Mild PE degeneration ODS NA
OS þ1.0 DS 20/40
62 OD þ1.5 DS þ1.5 DC 20/25 Protan/deutan
color blind
Missing cone response,
reduced rod response
Moderate macular PE atrophy
outer retinal thinning ODS
NA
OS þ1.0 DS þ2.0 DC 20/40
IV:7 51 OD 5.75 DS 2.0 DC 20/50 Protan/deutan
color blind
Mssing cone response,
reduced rod response
Mild to moderate macular PE
atrophy/outer retinal
thinning ODS
OD 27.82
OS 6.5 DS 0.5 DC 20/33 OS 27.57
V:1 32 NA 20/20 NA NA Normal macula with myopic
periferal fundus
OD 31.44
20/20 OS 30.72
38 OD 20.0 D SE 20/20 Normal color
vision
NA Mild macular PE atrophy with
myopic periferal fundus
NA
OS 18.0 D SE 20/20
46 OD 21.0 DS 4.0 DC 20/20 Protan/deutan
defects†
Missing cone,
reduced rod response
Moderate PE atrophy with
myopic periferal fundus
OD 33.11
OS 19.75 DS 2.5 DC 20/25 OS 32.28
V:3 42 OD 22.5 DS þ2.0 DC 20/20 Protan/deutan
defects†
NA Normal macula with Myopic
periferal fundus / normal
OCT
OD 31.35
OS 24.5 DS þ2.0 DC 20/20 OS 32.49
VI:6 11 OD 6.25 DS 3.75 DC 20/40‡ Normal color
vision
Reduced cone response,
normal rod response
Normal fundus NA
OS 6.5 DS 3.5 DC 20/20
Age represents the age at corresponding examinations. OD, right eye; OS, left eye; NA, not available.
* Patient IV:5 underwent corneal refractive surgery at the age of 40. Refraction values represent preoperative data.
† Normal with FM 100 Hue and Nagel anomaloscope, but shows both protan and deutan defects with pseudoisochromatic test plates.
‡ Patient VI:6 has an amblyopic right eye.
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FIGURE 2. Findings of ophthalmic imaging examinations. Color fundus photographs (A) autofluorescent fundus photos (B) and SD-OCT images (C)
for left eyes of three patients (VI:6, V:1, IV:5) and for right eye of one patient (IV:7). VI:6, aged 11 years, had normal fundus imaging, whereas all the
other patients who were 38 years and older (V:1, IV:7, IV:5) showed myopic fundus changes and macular abnormalities with mild to moderate
pigment epithelial atrophy. FAF images of VI:6, IV:7 patients showed central hyperreflective ring, a characteristic sign of cone dystrophies.
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FIGURE 3. Electroretinography recordings of affected individuals. Dark-adapted 0.01 ERG (rod response, L-Rod, R-Rod); dark-adapted 3.0 ERG
(maximal combined rod-cone response, L-max, R-max), light-adapted 3.0 ERG (single-flash photopic ERG, L-cone, R-cone), light-adapted 3.0 flicker
ERG (30-Hz flicker, L-30 Hz, R-30 Hz). Electrorintography images related to patient age. The youngest patient showed (VI:6) normal rod and reduced
cone response. Older patients (V:1, IV:7, IV:5) showed mildly reduced rod responses and moderate to severe cone dysfunction.
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questioned by the noncorresponding clinical phenotype.
Moreover, the mutation could not be detected with Sanger
sequencing in any other family members, ultimately excluding
it as a cause of the disease. On the other hand, Sanger
sequencing in all affected family members, making them the
only possible cause of the disease, could confirm the LVAVA
and MVAVA haplotypes. Normal haplotypes were detected with
neither of the sequencing methods indicating a mutated-only
genotype in the opsin gene array in all patients. The LVAVA
haplotype was found to cause the disease in the first two
families reported with BED and also in some other families
reported thereafter with the same genetic background and
comparable phenotype.14,27,29,32 However, findings in our
family show striking differences when compared with these
reports: our patients retained normal visual acuity and color
vision even in their middle ages and only thereafter did the
disease lead to progressive blue monochromatism and macular
dystrophy, a phenotype previously not described in association
with rare interchange haplotypes. It was previously shown,
that rare interchange haplotypes cause skipping of exon 3
introducing a frameshift and a premature stop codon.29,35
However, in contrast to the LIAVA haplotype, both MVAVA and
LVAVA haplotypes were shown to produce some amount of full
length mRNA.29 Accordingly, direct opsin inactivation by the
LIAVA haplotype leads to congenital color vision defect, while
LVAVA does not lead the direct color vision defect on its own.
Color vision defect observed in LVAVA patients was rather to be
accounted for by the absence of either the L- or the M-opsin
gene within the first two positions of the L/M-opsin gene
array.26,27,43 This observation explains the normal color vision
in our young patients and also the nonsyndromatous high
myopia associating to the LVAVA haplotype in two Chinese
TABLE 2. Summary of Variations Detected Both in IV:3 and V:1 Family Members Using Clinical Exome Sequencing
Gene
Coverage, -Fold
SNP ID
Nucleotide
Change
Amino Acid
Change MAFIV:3 V:1
VCX 61 6 rs75562767 c.209C>G p.Ala70Gly 0.67
104 15 rs80291436 c.311T>C p.Leu104Pro 0.46
117 29 rs78342118 c.581C>T p.Pro194Leu 0.42
CACNA1F* 31 12 rs150417702 c.1843G>T p.Ala615Ser <0.01
SLC16A2 45 15 rs6647476 c.97T>C p.Ser33Pro 0.66
KIAA2022† 143 57 rs41306133 c.2801A>G p.Asn934Ser 0.01
MAGT1 90 18 rs145245774 c.1028T>G p.Val343Gly 0.13
DIAPH2‡ 150 55 rs20361 c.1275C>A p.Phe425Leu <0.01
RBMXL3 29 13 rs6643947 c.3145A>G p.Arg1049Gly 0.11
LOC644717 25 17 rs6528273 c.1714G>T p.Val572Phe 0.66
SAGE1 66 23 rs4829799 c.2414T>C p.Leu805Ser 0.22
CSAG1 91 45 rs2515848 c.185A>G p.Lys62Arg 0.42
TMEM187 106 34 rs2266890 c.422C>T p.Ser141Leu 0.31
111 34 rs7350355 c.445A>G p.Met149Val 0.37
OPN1LW§ 135 55 rs145009674 c.532A>G p.Ile178Val 0.02
132 55 rs949431 c.538T>G p.Ser180Ala 0.2
OPN1MW§ 418 96 rs375538821 c.532A>G p.Ile178Val 0.02
* Associated phenotype: Aland Island eye disease, X- linked cone-rod dystrophy, X-linked congenital stationary night blindness.
† X-linked mental retardation.
‡ Premature ovarian failure.
§ Red-green color vision defects, BED, X- linked cone dystrophy, Blue cone monochromatism, X- linked nonsyndromic high myopia.
FIGURE 4. Electropherogram showing opsin variants detected by Sanger sequencing in the proband.
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families.33,34 The LVAVA haplotype differs from other inter-
change haplotypes in another aspect as well. BED was defined
as a nonprogressive eye disease and it was first described in
families with the LVAVA haplotype. In contrast to that, SD-
OCT and adaptive optics scanning light ophthalmoscopy
analysis showed disruption of the cone photoreceptor mosaic
and degenerative changes in the macula of patients with only
LVAVA haplotype indicating a progressive macular degenera-
tion.27,43 In contrast to that, LVAVA haplotype associated to
nonsyndromic high myopia in two Chinese families.33,34
However, the oldest family member (75-years old) having only
light perception visual acuity was excluded from further
clinical investigations due to senile cataract making any
ophthalmologic examinations impossible in the first family.
The next oldest patient was only 37-years old. Besides, there
was a patient with mild protanomaly reported from the same
family,33 and affected male family members had a visual acuity
between 0.1 and 0.2 in the second family.34 It is also to be
noted, that three patients in this family displayed mild to
moderate reduction in cone response upon ERG examination.
Our results indicate that late-onset progressive cone dystro-
phy might be a possible outcome in seemingly nonsyndromic
high myopia families with the LVAVA and MVAVA exon 3
interchange haplotype in the opsin genes. Accordingly, subtle
color vision defects and ERG alterations detected in these
Chinese families might indicate future clinical symptoms.
Normal color vision detected in young affected individuals in
the present family indicates that both haplotypes result in a
certain amount of normally spliced opsin mRNA and
functional opsin proteins. A progressive macular dystrophy
could be demonstrated in patients older than 40 years, which
finally led to combined red and green color blindness in the
two oldest patients. These data indicate that color vision
defect only develops along with cone dystrophy as a
consequence of the toxic effect rather than a direct opsin
inactivation of the LVAVA/MVAVA haplotypes. Here, we
confirm clinically for the first time that LVAVA and MVAVA
haplotypes do not cause color vision defect or impaired vision
in young individuals but cause late-onset progressive cone
dystrophy leading to a decline in visual acuity and color vision
defect in patients older than 40 years. This represents a novel
phenotype that has not been previously reported to associate
to any of the rare exon 3 interchange haplotypes. Our results
add substantial new knowledge to the understanding of
genotype–phenotype correlation and disease course of the
corresponding rare exon 3 interchange haplotypes. Our
report highlights that clinical phenotype associating to
LVAVA/MVAVA exon 3 interchange haplotype in the opsin
genes may only manifest in older individuals. However,
further studies are needed to elucidate the course of the
disease in individuals older than here presented. Moreover,
recognizing this novel genotype–phenotype association could
be essential as soon as gene therapy is applied in opsin-related
diseases. In that case, this genotype could be of special
interest with its long asymptomatic period providing a large
therapeutic time window.
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